FDA Guidance On Peripheral Neuropathy Drugs In The Works
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is holding a public workshop to discuss therapeutic targets and clinical trial design for disease-modifying agents to treat peripheral neuropathy; many products in recent development have faced challenges.